These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 3012210

  • 1. In-vitro effects of antineoplastic prostaglandins on human leukemic cell growth and normal myelopoiesis.
    Tsao CJ, Ozawa K, Hosoi T, Urabe A, Takaku F.
    Leuk Res; 1986; 10(5):527-32. PubMed ID: 3012210
    [Abstract] [Full Text] [Related]

  • 2. Role of adenosine 3'5'-cyclic monophosphate in antineoplastic effect of prostaglandins (PGE1, PGE2, PGD2 and PGA1) on human neuroblastoma cells.
    Hashida T, Todo S, Imashuku S.
    Prostaglandins Leukot Essent Fatty Acids; 1988 Jul; 33(1):61-8. PubMed ID: 2847201
    [Abstract] [Full Text] [Related]

  • 3. Novel mechanism of heterologous desensitization of adenylate cyclase: prostaglandins bind with different affinities to both stimulatory and inhibitory receptors on platelets.
    Ashby B.
    Mol Pharmacol; 1990 Jul; 38(1):46-53. PubMed ID: 1695318
    [Abstract] [Full Text] [Related]

  • 4. Prostaglandin D2 inhibits the proliferation of human neuroblastoma cells.
    Sakai T, Yamaguchi N, Kawai K, Nishino H, Iwashima A.
    Cancer Lett; 1983 Jan; 17(3):289-94. PubMed ID: 6572553
    [Abstract] [Full Text] [Related]

  • 5. delta 12-Prostaglandin J2, an ultimate metabolite of prostaglandin D2 exerting cell growth inhibition.
    Narumiya S, Fukushima M.
    Biochem Biophys Res Commun; 1985 Mar 29; 127(3):739-45. PubMed ID: 3857041
    [Abstract] [Full Text] [Related]

  • 6. In vitro modulation of proliferation and melanization of S91 melanoma cells by prostaglandins.
    Abdel-Malek ZA, Swope VB, Amornsiripanitch N, Nordlund JJ.
    Cancer Res; 1987 Jun 15; 47(12):3141-6. PubMed ID: 2438034
    [Abstract] [Full Text] [Related]

  • 7. Effects of prostaglandin E on the proliferation and differentiation of leukemic progenitor cells in acute nonlymphocytic leukemia.
    Ozawa K, Miura Y, Suda T, Motoyoshi K, Takaku F.
    Int J Cell Cloning; 1983 Dec 15; 1(6):440-50. PubMed ID: 6584501
    [Abstract] [Full Text] [Related]

  • 8. Cycloheximide reduces PGD2 or delta 12-PGJ2 cytotoxicity on NCG cells.
    Shimizu Y, Todo S, Imashuku S.
    Prostaglandins; 1986 Oct 15; 32(4):517-25. PubMed ID: 3099333
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of prostaglandin D2 (PGD2) as an anticoagulative agent for haemodialysis in comparison with prostaglandin E1 (PGE1).
    Nakagawa S, Matsui N, Akiba T, Shinoda T, Fukudome Y, Ozawa K, Baba M, Nakanishi T, Takeuchi J.
    Proc Eur Dial Transplant Assoc; 1981 Oct 15; 18():117-21. PubMed ID: 7036145
    [Abstract] [Full Text] [Related]

  • 10. [Antineoplastic action of prostaglandin D2--effect of PGD2 on proliferation of L1210 leukemic cells in culture].
    Fukushima M, Kato T, Ota K.
    Gan To Kagaku Ryoho; 1982 Jan 15; 9(1):159-60. PubMed ID: 6964030
    [Abstract] [Full Text] [Related]

  • 11. [Development of antineoplastic prostaglandins].
    Fukushima M.
    Gan To Kagaku Ryoho; 1983 Sep 15; 10(9):1930-5. PubMed ID: 6577812
    [Abstract] [Full Text] [Related]

  • 12. The cytoplasmic concentration of free calcium in platelets is controlled by stimulators of cyclic AMP production (PGD2, PGE1, forskolin).
    Feinstein MB, Egan JJ, Sha'afi RI, White J.
    Biochem Biophys Res Commun; 1983 Jun 15; 113(2):598-604. PubMed ID: 6307295
    [Abstract] [Full Text] [Related]

  • 13. The effects of PGD2 and 9-deoxy-delta 9-PGD2 on colony formation of murine osteosarcoma cells.
    Tanaka H, Yamamuro T, Matsumoto M, Kotoura Y, Tanaka C.
    Prostaglandins; 1985 Jul 15; 30(1):167-74. PubMed ID: 3863195
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Control of cell cycle by metabolites of prostaglandin D2 through a non-cAMP mediated mechanism.
    Hughes-Fulford M, Fukushima M.
    Life Sci Adv Exp Clin Endocrinol; 1993 Jul 15; 12():57-64. PubMed ID: 11539936
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.